5Johnson R J, Lombardi D, Eng E, et al. Modulation of experimental mesangial proliferative nephritis by interferon- gamma. Kidney Int, 1995,47( 1 ) : 62 - 69.
6Varga J, Yufit T, Hitraya E, et al. Control of extracellular matrix degradation by interferon - γ', in Recent Advances in Tryptophan Research. Edited by Filippini GA. New York:Plenum Press, 1996,143 - 148.
7Strum F, Heeg M, Kochsiek T, et al. Effects of pentoxifylline, pentifylline and γ- interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrol Dial Transplant, 2000,15 : 1535 - 1546.
8Ginevri F, 13crgarnaschi E, Mutti A, et al. Protracted high-dose interferon gamma therapy for chronic experimental nephropathy. Life Sci, 1994,54( 1 ) :45 - 50.
2Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol, 1996,7:2495-2508.
3Alpers CE, Hudkins KL, Gown AM, et al. Enhanced expression of musc le-specific actin in glomerulonephritis. Kidney Int, 1992,41:1134-1142.
4Alpers CE, Hudkins KL, Floege J, et al. Human renal cortical interstit ial cel ls with some features of smooth muscle cells participate in tubulointerstitral a nd crescentic glomerular injury. J Am Soc Nephrol, 1994,5:201-209.
5Diamond JR, van Goor H, Ding G, et al. Myofibroblasts in experimental hydronephrosis. Am J Pathol, 1995,146:121-129.
6Hewitson TD, Wu HL, Becker GJ. Interstitial myofibroblasts in experime ntal renal infection and scarring. Am J Nephrol, 1995,15:411-417.
7Hewitson TD, Becker GJ. Intertitial myofibroblasts in lgA glomerulonep hritis. Am J Nephrol, 1995,15:111-117.
8Zhang G, Moorhead PJ, EL Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol, 1995,3:308-318.
9Tang WW, UlichTR, Lancey DL, et al. Platelet-derives growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosi s. Am J Pathol, 1996,148:1169-1180.
10Strutz F. Transdifferentiation: a new concept in renal fibrogenesis. J Am Soc Nephrol, 1994, 5:819-822.
3Ebihara I, Hirayama K, Yamamoto S, et al. Th2 predominance at the single-cell level in patients with IgA nephropathy[ J]. Nephrol Dial Transplant,2001,16(9) :1783 - 1789.
4Mum K, Yamagata K, Kobayashi M, et al. Usage of T cell receptor variable segments of the beta-chain in IgA nephropathy [ J ]. Neph- ron,2002,92( 1 ) :56 - 63.
5Lee SM, Rao VM, Franklin WA, et al. IgA Nephropathy: Morphologic Predictors of Progressive Renal Disease [ J ]. Hum Pathol, 1982, 13(4) :314 -322.
6Ebihara I, Hirayama K, Yamamoto S, et al. Th2 predominance at the single-cell level in patients with lgA nephropathy [ J ]. Nephrel Dial Transplant,2001,16 (9) : 1783 - 1789.
7Yano N, Endoh M, Takemura F, et al. Involvement of interleukin-4- and soluble CD23 in hypersynthesis of immunoglobulins A and E in patients with lgA nephropathy[ J]. Nephron, 1996,72 ( 1 ) :44 - 51.
8Ichinose H, Miyazaki M, Koji T, et al. Detection of cytokine mRNA- expressing cells in peripheral blood of patients with lgA nephropathy using non-radioactive in situ hybridization [ J ]. Clin Exp Immunol, 1996,103 ( 1 ) : 125 - 132.
9Suzuki H, Suzuki Y, Aizawa M, et al. Thl polarization in murine IgA nephropathy directed by bone marrow-derived cells [ J]. Kidney Int, 2007,72(3) :319 -327.
10Masutani K, Miyake K, Nakashima H, et al. Impact of interferon-3, and interleukin-4 polymorphisms on development and progression of IgA nephropathy in Japanese patients [ J ]. Am J Kidney Dis, 2003, 41(27 :E371 -379.
